CN1251655C - 快速生物封闭止血装置及其制造工艺 - Google Patents
快速生物封闭止血装置及其制造工艺 Download PDFInfo
- Publication number
- CN1251655C CN1251655C CN 03126852 CN03126852A CN1251655C CN 1251655 C CN1251655 C CN 1251655C CN 03126852 CN03126852 CN 03126852 CN 03126852 A CN03126852 A CN 03126852A CN 1251655 C CN1251655 C CN 1251655C
- Authority
- CN
- China
- Prior art keywords
- thrombin
- content
- fibrinogen
- layer
- hemostasis device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 230000002439 hemostatic effect Effects 0.000 title abstract description 8
- 108090000190 Thrombin Proteins 0.000 claims abstract description 39
- 229960004072 thrombin Drugs 0.000 claims abstract description 39
- 102000008186 Collagen Human genes 0.000 claims abstract description 27
- 108010035532 Collagen Proteins 0.000 claims abstract description 27
- 108010049003 Fibrinogen Proteins 0.000 claims abstract description 21
- 102000008946 Fibrinogen Human genes 0.000 claims abstract description 21
- 229940012952 fibrinogen Drugs 0.000 claims abstract description 21
- 238000005516 engineering process Methods 0.000 claims abstract description 11
- 230000023597 hemostasis Effects 0.000 claims description 22
- 238000007789 sealing Methods 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000011716 vitamin B2 Substances 0.000 claims description 9
- 229910001424 calcium ion Inorganic materials 0.000 claims description 8
- 102000007327 Protamines Human genes 0.000 claims description 7
- 108010007568 Protamines Proteins 0.000 claims description 7
- 229920000669 heparin Polymers 0.000 claims description 7
- 239000002607 heparin antagonist Substances 0.000 claims description 7
- 229940048914 protamine Drugs 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 230000008014 freezing Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 241000282898 Sus scrofa Species 0.000 claims description 4
- 241000282894 Sus scrofa domesticus Species 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- 108010039627 Aprotinin Proteins 0.000 claims description 3
- 229960004405 aprotinin Drugs 0.000 claims description 3
- 230000001723 fibrinogenic effect Effects 0.000 claims description 3
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 150000004965 peroxy acids Chemical class 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 229940003871 calcium ion Drugs 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 5
- 238000013329 compounding Methods 0.000 abstract 4
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 2
- 239000003114 blood coagulation factor Substances 0.000 abstract 2
- 229940019700 blood coagulation factors Drugs 0.000 abstract 2
- 230000007547 defect Effects 0.000 abstract 1
- 230000009982 effect on human Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000007788 liquid Substances 0.000 description 5
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 230000000025 haemostatic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011082 depyrogenation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03126852 CN1251655C (zh) | 2003-06-13 | 2003-06-13 | 快速生物封闭止血装置及其制造工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03126852 CN1251655C (zh) | 2003-06-13 | 2003-06-13 | 快速生物封闭止血装置及其制造工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1460458A CN1460458A (zh) | 2003-12-10 |
CN1251655C true CN1251655C (zh) | 2006-04-19 |
Family
ID=29591102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03126852 Expired - Fee Related CN1251655C (zh) | 2003-06-13 | 2003-06-13 | 快速生物封闭止血装置及其制造工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1251655C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178975B (zh) * | 2011-04-25 | 2013-10-23 | 福建南生科技有限公司 | 纤维蛋白止血贴及其制作方法 |
JP6025824B2 (ja) * | 2011-05-24 | 2016-11-16 | タケダ エイエスTakeda AS | 巻回されたコラーゲン支持体 |
CN102940551B (zh) * | 2012-11-20 | 2014-07-23 | 广州创尔生物技术股份有限公司 | 一种高浓度胶原海绵护创贴及其制备方法 |
CN104524603B (zh) * | 2014-12-30 | 2018-09-25 | 广州市拜特凇医药科技有限公司 | 可被生物机体吸收的止血生物制品/生物材料的病毒去除/灭活方法 |
CN106427179A (zh) * | 2016-09-22 | 2017-02-22 | 河南工业大学 | 一种麦胚蛋白止血贴的制备方法 |
-
2003
- 2003-06-13 CN CN 03126852 patent/CN1251655C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1460458A (zh) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2702339C1 (ru) | Уплотненные гемостатические целлюлозные агрегаты | |
AU2018274924A1 (en) | Hemostatic compositions | |
EP0092200B1 (de) | Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung | |
Jang et al. | Improving mechanical properties of alginate hydrogel by reinforcement with ethanol treated polycaprolactone nanofibers | |
CA2207289C (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
US9517287B2 (en) | Hemostatic sponge | |
EP2600910B1 (en) | Dry composition wound dressings and adhesives | |
CN108472404B (zh) | 止血组合物 | |
US20040191277A1 (en) | Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use | |
CA2964501C (en) | A biomaterial scaffold for regenerating the oral mucosa | |
CN110339393B (zh) | 一种基于水凝胶-核壳微球的创伤敷料及其制备方法 | |
AU2017311658B2 (en) | Hemostatic compositions and methods of making thereof | |
CA2684258A1 (en) | Compositions comprising plant extracts and methods of treating wounds, burns and skin injuries therewith | |
JP7204784B2 (ja) | 止血組成物の製造方法 | |
CA2399211A1 (en) | Foam-forming wound dressing | |
CN1251655C (zh) | 快速生物封闭止血装置及其制造工艺 | |
CN104546893A (zh) | 一种可生物降解吸收的止血组合物 | |
Venugopal et al. | Electrospun plant-derived natural biomaterials for tissue engineering | |
AU2016317642A1 (en) | Products and methods using a platelet-derived hemostatic agent for controlling bleeding and improving healing | |
CN110237094B (zh) | 一种底层血小板因子贴及sPL血小板因子凝胶贴膜的制备方法 | |
WO2002070795A1 (en) | Elongated biopolymer structure containing fibrin | |
WO2011050622A1 (zh) | 一种用于组织修复的颗粒状生物材料及其制备方法 | |
KR20190123316A (ko) | 용매 침착 시스템 및 방법 | |
Jose et al. | Herbal extracts based scaffolds for wound healing therapy | |
RU2741304C2 (ru) | Гемостатическая композиция |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHANG CHUNRONG Free format text: FORMER OWNER: GUANGZHOU BEIXIU BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20040322 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20040322 Address after: 510620, room K.L, 32 / F, Guangzhou International Trade Center, No. 1 Lin Xi Road, Guangdong, Guangzhou Applicant after: Chang Chunrong Address before: 510620, room K.L, 32 / F, Guangzhou International Trade Center, No. 1 Lin Xi Road, Guangdong, Guangzhou Applicant before: Guangzhou Beixiu Biotechnology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060419 Termination date: 20180613 |
|
CF01 | Termination of patent right due to non-payment of annual fee |